Armistice Capital reports 9.99% stake in Avalon Globocare
Avalon Globocare Corp. disclosed a joint Schedule 13G filing showing Armistice Capital, LLC and Steven Boyd report 890,521 shares, representing 9.99% of the common stock (CUSIP 05344R302).
Rhea-AI Filing Summary
Avalon Globocare Corp. disclosed a joint Schedule 13G filing showing Armistice Capital, LLC and Steven Boyd report 890,521 shares, representing 9.99% of the common stock (CUSIP 05344R302). Armistice Capital is the investment manager of the Master Fund and reports shared voting and dispositive power over these shares.
Positive
- None.
Negative
- None.
Insights
Armistice Capital reports a near-10% passive stake with shared voting power.
Armistice Capital and Steven Boyd jointly report beneficial ownership of 890,521 shares (9.99%). The filing characterizes Armistice as manager of the Master Fund and discloses shared voting and dispositive power, consistent with an investment manager relationship.
This Schedule 13G indicates disclosure of a substantial passive holding; subsequent filings could clarify any change in intent or voting arrangements.
Filing clarifies who exercises voting and disposition authority over the reported holdings.
The statement explains that the Master Fund is the direct holder while Armistice Capital exercises voting and investment power under an Investment Management Agreement. Mr. Boyd, as managing member, is disclosed as potentially deemed to beneficially own the securities.
Investor relations should note the 9.99% position and the identity of the reporting persons for disclosure tracking.
Key Figures
Key Terms
Investment Management Agreement regulatory
Beneficial ownership regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Armistice Capital report in Avalon Globocare (ALBT)?
Who is disclosed as the reporting person alongside Armistice Capital in the 13G?
AI-generated analysis. How Rhea-AI works. Not financial advice.